Catalyst Wire Dossier Catalyst Wire Dossier

Continuous glucose monitor (CGM) device

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Continuous glucose monitor (CGM) device, covering 2024-09-27 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland [NA]

See pricing